Pagina di risultati 9 per Industria: Biotecnologia Settore: Salute Mercato azionario - Quotazioni e prezzi
Elenco di tutte le azioni e i titoli con prezzi, capitalizzazione, PE ed EPS
Tutti i paesi
Tutte le borse
Salute (1574)
Biotecnologia (1574)
Mappa di calore del mercato
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS | Previsione |
|---|
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS | Previsione | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|||||||||
Matinas BioPharma
MTNB
US
|
$0.80 — |
-1.26
|
$890.71K — | $37.09K — | $0.75 — | $0.80 — | $890.71K — | 0 | -$24.01 — |
|
|
ASEP Medical Holdings Inc.
ASEP.CN
CA
|
CA$0.10 0.07 USD |
0
|
CA$1.11M 825.71K USD | CA$0.00 0 USD | CA$0.10 0.07 USD | CA$0.10 0.07 USD | CA$1.11M 825.71K USD | 0 | -CA$0.37 -0.2 USD | ||
ProtoKinetix
PKTX
US
|
$0.00 — |
0
|
$824.26K — | $2.96K — | $0.01 — | $0.01 — | $824.26K — | 0 | $0.00 — | ||
Oragenics
OGEN
US
|
$0.16 — |
-8.72
|
$708.38K — | $323.08K — | $0.16 — | $0.18 — | $708.38K — | 0 | -$1.05 — |
|
|
Protagenic Therapeutics
PTIX
US
|
$0.38 — |
-9.52
|
$687.88K — | $15.51K — | $0.35 — | $0.48 — | $687.88K — | 0.16 | $2.33 — |
|
|
IntegraGen SA
ALINT.PA
FR
|
€0.08 0.08 USD |
0
|
€491.77K 539.69K USD | €27.42K 30.09K USD | €0.07 0.07 USD | €0.08 0.08 USD | €491.77K 539.69K USD | 0 | -€0.02 -0.02 USD | ||
Magle Chemoswed Holding AB
MAGLE.ST
SE
|
SEK 0.25 0.02 USD |
-38.05
|
SEK 5.24M 511.97K USD | SEK 357.79K 34.92K USD | SEK 0.22 0.02 USD | SEK 0.44 0.04 USD | SEK 5.24M 511.97K USD | 0 | -SEK 8.23 -0.8 USD | ||
Appili Therapeutics Inc.
APLI.TO
CA
|
CA$0.00 0.0037 USD |
-50
|
CA$661.83K 491.12K USD | CA$117.00K 86.82K USD | CA$0.00 0.0037 USD | CA$0.00 0.0037 USD | CA$661.83K 491.12K USD | 0 | -CA$0.04 -0.02 USD | ||
SciSparc
SPRC
US
|
$0.20 — |
-34.83
|
$481.60K — | $4.55M — | $0.17 — | $0.26 — | $481.60K — | 0.00078 | $248.24 — |
|
|
Regen BioPharma
RGBP
US
|
$0.00 — |
+100
|
$405.85K — | $12.56M — | $0.00 — | $0.00 — | $405.85K — | 0 | -$0.02 — | ||
Aditxt
ADTX
US
|
$0.00 — |
+33.33
|
$399.19K — | $9.76M — | $0.00 — | $0.00 — | $399.19K — | 0 | $25.45M — |
|
|
Chimeric Therapeutics Limited
CHM.AX
AU
|
A$0.00 0.0020 USD |
0
|
A$442.39K 309.04K USD | A$25.13M 17.55M USD | A$0.00 0.0020 USD | A$0.00 0.0027 USD | A$442.39K 309.04K USD | 0 | -A$0.61 -0.4 USD | ||
Oxurion NV
OXUR.BR
BE
|
€0.00 0.0010 USD |
0
|
€232.00K 254.61K USD | €4.58M 5.02M USD | €0.00 0.0010 USD | €0.00 0.0015 USD | €232.00K 254.61K USD | 0.010 | €0.10 0.11 USD | ||
Endonovo Therapeutics
ENDV
US
|
$0.00 — |
0
|
$180.76K — | $409.41K — | $0.00 — | $0.00 — | $180.76K — | 0 | $0.00 — | ||
Innovation Pharmaceuticals
IPIX
US
|
$0.00 — |
0
|
$103.67K — | $12.60K — | $0.00 — | $0.01 — | $103.67K — | 0 | -$0.01 — | ||
BioLineRx Ltd.
BLRX.TA
IL
|
ILA 1.00 0.0029 USD |
0
|
ILA 29.87M 87.1K USD | ILA 20.00K 58.32 USD | ILA 1.00 0.0029 USD | ILA 1.00 0.0029 USD | ILA 29.87M 87.1K USD | 0 | ILA 0.00 0 USD | ||
GB Sciences
GBLX
US
|
$0.00 — |
+100
|
$81.41K — | $31.00K — | $0.00 — | $0.00 — | $81.41K — | 0 | $0.00 — | ||
Nascent Biotech
NBIO
US
|
$0.00 — |
+50
|
$51.67K — | $15.00K — | $0.00 — | $0.00 — | $51.67K — | 0 | -$0.01 — | ||
Medigene AG
MDG1.HM
DE
|
€0.00 0.0032 USD |
-6.25
|
€44.21K 48.52K USD | €10.39K 11.4K USD | €0.00 0.0032 USD | €0.00 0.0035 USD | €44.21K 48.52K USD | 0 | -€0.16 -0.1 USD | ||
Burzynski Research Institute
BZYR
US
|
$0.00 — |
0
|
$26.29K — | $60.00K — | $0.00 — | $0.00 — | $26.29K — | 0 | -$0.01 — | ||
Bio-Path
BPTH
US
|
$0.00 — |
0
|
$15.09K — | $104.00 — | $0.00 — | $0.00 — | $15.09K — | 0 | -$1.14 — | ||
Windtree Therapeutics
WINT
US
|
$0.00 — |
-33.33
|
$6.74K — | $70.00K — | $0.01 — | $0.01 — | $6.74K — | 0.00000061 | $323.19 — | ||
Fortress Biotech
FBIOP
US
|
$13.60 — |
-1.09
|
$0.00 — | $27.65K — | $13.36 — | $13.80 — | $0.00 — | 0 | -$0.86 — |
|
|
Regen BioPharma
RGBPP
US
|
$0.00 — |
+25
|
$0.00 — | $56.00 — | $0.00 — | $0.00 — | $0.00 — | 0 | -$0.02 — | ||
Vertex Pharmaceuticals Incorporated
VRTX34.SA
BR
|
R$96.21 19.5 USD |
-2.15
|
R$780.57B 158.21B USD | R$646.00 130.93 USD | R$96.21 19.5 USD | R$98.70 20 USD | R$780.57B 158.21B USD | 38.02 | R$2.53 0.51 USD | ||
Vertex Pharmaceuticals Incorporated
VRTX.MX
MX
|
MX$9,936.00 588.33 USD |
+0.11
|
MX$2.52T 149.16B USD | MX$52.00 3.08 USD | MX$9,936.00 588.33 USD | MX$9,936.00 588.33 USD | MX$2.52T 149.16B USD | 36.22 | MX$274.28 16.24 USD | ||
Vertex Pharmaceuticals Incorporated
VRTX.VI
AT
|
€477.90 524.47 USD |
+0.06
|
€121.17B 132.97B USD | €0.00 0 USD | €477.90 524.47 USD | €479.75 526.5 USD | €121.17B 132.97B USD | 35.74 | €13.37 14.67 USD | ||
Vertex Pharmaceuticals Incorporated
VX1.DE
DE
|
€477.45 523.98 USD |
-0.22
|
€121.05B 132.85B USD | €42.00 46.09 USD | €475.65 522 USD | €483.80 530.95 USD | €121.05B 132.85B USD | 35.76 | €13.35 14.65 USD | ||
Vertex Pharmaceuticals Incorporated
VX1.F
DE
|
€477.05 523.54 USD |
-0.61
|
€120.95B 132.74B USD | €32.00 35.12 USD | €469.40 515.14 USD | €477.75 524.31 USD | €120.95B 132.74B USD | 35.89 | €13.29 14.59 USD | ||
Regeneron Pharmaceuticals, Inc.
REGN34.SA
BR
|
R$91.33 18.51 USD |
-1.28
|
R$566.87B 114.9B USD | R$146.00 29.59 USD | R$91.27 18.5 USD | R$93.72 19 USD | R$566.87B 114.9B USD | 23.23 | R$3.93 0.8 USD | ||
Regeneron Pharmaceuticals, Inc.
REGN.MX
MX
|
MX$17,710.00 1048.65 USD |
0
|
MX$1.83T 108.48B USD | MX$130.00 7.7 USD | MX$17,710.00 1048.65 USD | MX$17,710.00 1048.65 USD | MX$1.83T 108.48B USD | 22.17 | MX$798.49 47.28 USD | ||
Regeneron Pharmaceuticals, Inc.
RGO.DE
DE
|
€849.00 931.74 USD |
-0.29
|
€87.83B 96.39B USD | €50.00 54.87 USD | €841.50 923.51 USD | €849.00 931.74 USD | €87.83B 96.39B USD | 21.87 | €38.82 42.6 USD | ||
Regeneron Pharmaceuticals, Inc.
REGN.VI
AT
|
€848.80 931.52 USD |
-2.78
|
€87.81B 96.36B USD | €0.00 0 USD | €844.10 926.36 USD | €848.80 931.52 USD | €87.81B 96.36B USD | 21.79 | €38.94 42.73 USD | ||
Regeneron Pharmaceuticals, Inc.
RGO.F
DE
|
€837.10 918.68 USD |
-0.91
|
€86.60B 95.04B USD | €30.00 32.92 USD | €837.10 918.68 USD | €839.10 920.87 USD | €86.60B 95.04B USD | 21.69 | €38.58 42.34 USD | ||
Moderna, Inc.
MRNA.MX
MX
|
MX$3,730.00 220.86 USD |
-2.61
|
MX$1.51T 89.37B USD | MX$188.00 11.13 USD | MX$3,730.00 220.86 USD | MX$3,890.00 230.34 USD | MX$1.51T 89.37B USD | 0 | -MX$124.20 -7.3 USD | ||
Moderna, Inc.
MRNA.VI
AT
|
€182.98 200.81 USD |
+0.27
|
€74.04B 81.25B USD | €57.00 62.55 USD | €178.64 196.05 USD | €182.98 200.81 USD | €74.04B 81.25B USD | 0 | -€6.06 -6.6 USD | ||
Moderna, Inc.
0QF.MU
DE
|
€178.96 196.4 USD |
-1.91
|
€72.41B 79.47B USD | €9.00 9.88 USD | €178.96 196.4 USD | €180.56 198.16 USD | €72.41B 79.47B USD | 0 | -€5.94 -6.5 USD | ||
Moderna, Inc.
0QF.F
DE
|
€174.26 191.24 USD |
-4.05
|
€70.51B 77.38B USD | €580.00 636.52 USD | €174.26 191.24 USD | €190.12 208.65 USD | €70.51B 77.38B USD | 0 | -€5.81 -6.3 USD | ||
argenx SE
A1RG34.SA
BR
|
R$220.00 44.59 USD |
0
|
R$345.87B 70.1B USD | R$0.00 0 USD | R$220.00 44.59 USD | R$220.00 44.59 USD | R$345.87B 70.1B USD | 36.48 | R$6.03 1.22 USD | ||
CSL
CMXHF
US
|
$128.26 — |
0
|
$61.55B — | $500.00 — | $135.00 — | $135.00 — | $61.55B — | 0 | -$5.35 — |
|
|
CSL Limited
CSJA.F
DE
|
€29.00 31.83 USD |
+1.4
|
€55.67B 61.09B USD | €40.00 43.9 USD | €28.40 31.17 USD | €29.00 31.83 USD | €55.67B 61.09B USD | 0 | -€1.16 -1.2 USD | ||
UCB
UCBJF
US
|
$318.32 — |
-1.17
|
$60.69B — | $777.00 — | $325.00 — | $325.00 — | $60.69B — | 24.11 | $13.20 — |
|
|
argenx
ARGNF
US
|
$965.00 — |
0
|
$60.69B — | $49.00 — | $995.00 — | $995.00 — | $60.69B — | 33.42 | $28.87 — |
|
|
CSL Limited
CSJ.F
DE
|
€114.86 126.05 USD |
-4.9
|
€55.12B 60.49B USD | €110.00 120.72 USD | €114.86 126.05 USD | €118.24 129.76 USD | €55.12B 60.49B USD | 0 | -€4.36 -4.7 USD | ||
argenx SE
1AEA.MU
DE
|
€860.00 943.81 USD |
-1.15
|
€54.08B 59.35B USD | €0.00 0 USD | €860.00 943.81 USD | €860.00 943.81 USD | €54.08B 59.35B USD | 35.01 | €24.56 26.95 USD | ||
argenx SE
ARGX.VI
AT
|
€853.40 936.57 USD |
+0.05
|
€53.67B 58.9B USD | €0.00 0 USD | €853.20 936.35 USD | €853.40 936.57 USD | €53.67B 58.9B USD | 34.34 | €24.85 27.27 USD | ||
UCB SA
UCB.VI
AT
|
€281.40 308.82 USD |
-0.42
|
€53.65B 58.88B USD | €0.00 0 USD | €280.90 308.27 USD | €283.20 310.8 USD | €53.65B 58.88B USD | 24.85 | €11.32 12.42 USD | ||
argenx SE
1AE.F
DE
|
€845.60 928.01 USD |
-1.67
|
€53.18B 58.36B USD | €1.00 1.1 USD | €845.60 928.01 USD | €845.60 928.01 USD | €53.18B 58.36B USD | 34.61 | €24.43 26.81 USD | ||
UCB SA
UNC.F
DE
|
€277.80 304.87 USD |
-2.9
|
€52.97B 58.13B USD | €60.00 65.85 USD | €277.80 304.87 USD | €282.40 309.92 USD | €52.97B 58.13B USD | 25.27 | €10.99 12.06 USD | ||
argenx SE
1AEA.F
DE
|
€810.00 888.94 USD |
-1.82
|
€50.94B 55.9B USD | €2.00 2.19 USD | €810.00 888.94 USD | €810.00 888.94 USD | €50.94B 55.9B USD | 33.19 | €24.40 26.78 USD | ||
Samsung Biologics Co.,Ltd.
207940.KS
KR
|
₩1,355,000 1022.8 USD |
-1.45
|
₩66T 49.62B USD | ₩40K 30.23 USD | ₩1,321,000 997.14 USD | ₩1,382,000 1043.18 USD | ₩66T 49.62B USD | 0 | ₩0 0 USD | ||
BeOne Medicines AG
49BA.F
DE
|
€348.00 381.91 USD |
-3.87
|
€39.75B 43.62B USD | €15.00 16.46 USD | €348.00 381.91 USD | €348.00 381.91 USD | €39.75B 43.62B USD | 53.95 | €6.45 7.08 USD | ||
Royalty Pharma plc
RPRXN.MX
MX
|
MX$1,213.52 71.86 USD |
0
|
MX$697.76B 41.32B USD | MX$2.90K 171.72 USD | MX$1,213.52 71.86 USD | MX$1,213.52 71.86 USD | MX$697.76B 41.32B USD | 44.94 | MX$27.00 1.6 USD | ||
Genmab A/S
0MGB.IL
GB
|
DKK 3,469.00 508.63 USD |
-0.8
|
DKK 277.80B 40.73B USD | DKK 19.67K 2.88K USD | DKK 3,469.00 508.63 USD | DKK 3,517.00 515.67 USD | DKK 277.80B 40.73B USD | 49.01 | DKK 70.77 10.38 USD | ||
Royalty Pharma plc
RPD.MU
DE
|
€62.14 68.2 USD |
-0.5
|
€35.73B 39.21B USD | €0.00 0 USD | €62.14 68.2 USD | €62.14 68.2 USD | €35.73B 39.21B USD | 47.43 | €1.31 1.44 USD | ||
Royalty Pharma plc
RPD.F
DE
|
€61.01 66.96 USD |
+0.46
|
€35.08B 38.5B USD | €150.00 164.62 USD | €61.01 66.96 USD | €61.01 66.96 USD | €35.08B 38.5B USD | 46.21 | €1.32 1.45 USD | ||
Celltrion, Inc.
068270.KS
KR
|
₩213,000 160.78 USD |
-0.93
|
₩48T 36.58B USD | ₩588K 444.1 USD | ₩211,000 159.27 USD | ₩216,500 163.42 USD | ₩48T 36.58B USD | 0 | ₩0 0 USD | ||
Revolution Medicines, Inc.
42Z.F
DE
|
€150.00 164.62 USD |
+1.11
|
€32.44B 35.61B USD | €976.00 1.07K USD | €143.75 157.76 USD | €151.00 165.72 USD | €32.44B 35.61B USD | 0 | -€7.95 -8.7 USD | ||
Insmed Incorporated
IM8N.F
DE
|
€133.30 146.29 USD |
+6.76
|
€29.24B 32.09B USD | €398.00 436.79 USD | €130.56 143.28 USD | €133.30 146.29 USD | €29.24B 32.09B USD | 0 | -€2.58 -2.8 USD | ||
Genmab A/S
GE91.F
DE
|
€46.60 51.14 USD |
0
|
€28.73B 31.53B USD | €62.00 68.04 USD | €46.40 50.92 USD | €46.60 51.14 USD | €28.73B 31.53B USD | 46.13 | €1.01 1.11 USD | ||
Genmab
GNMSF
US
|
$509.60 — |
+1.16
|
$31.42B — | $6.00 — | $495.75 — | $497.69 — | $31.42B — | 43.55 | $11.70 — |
|
|
Genmab A/S
GE9.DE
DE
|
€463.70 508.89 USD |
-2.11
|
€28.59B 31.38B USD | €22.00 24.14 USD | €463.70 508.89 USD | €468.20 513.83 USD | €28.59B 31.38B USD | 47.02 | €9.86 10.82 USD | ||
Insmed Incorporated
IM8N.SG
DE
|
€128.72 141.26 USD |
-1.98
|
€28.24B 30.99B USD | €100.00 109.75 USD | €128.72 141.26 USD | €133.16 146.14 USD | €28.24B 30.99B USD | 0 | -€2.37 -2.6 USD | ||
Incyte Corporation
I1NC34.SA
BR
|
R$347.20 70.37 USD |
-0.57
|
R$141.54B 28.69B USD | R$163.00 33.04 USD | R$343.35 69.59 USD | R$364.35 73.85 USD | R$141.54B 28.69B USD | 67.94 | R$5.11 1.04 USD | ||
Roivant Sciences Ltd.
87S.F
DE
|
€34.64 38.02 USD |
+0.2
|
€25.10B 27.54B USD | €500.00 548.73 USD | €34.64 38.02 USD | €35.11 38.53 USD | €25.10B 27.54B USD | 0 | -€0.56 -0.6 USD | ||
Incyte Corporation
INCY.MX
MX
|
MX$2,215.00 131.16 USD |
0
|
MX$451.49B 26.73B USD | MX$410.00 24.28 USD | MX$2,215.00 131.16 USD | MX$2,215.00 131.16 USD | MX$451.49B 26.73B USD | 64.03 | MX$34.59 2.05 USD | ||
BioNTech SE
BNTXN.MX
MX
|
MX$1,650.00 97.7 USD |
0
|
MX$409.08B 24.22B USD | MX$0.00 0 USD | MX$1,650.00 97.7 USD | MX$1,650.00 97.7 USD | MX$409.08B 24.22B USD | 0 | -MX$120.50 -7.1 USD | ||
BioNTech SE
B1NT34.SA
BR
|
R$30.10 6.1 USD |
-1.67
|
R$119.40B 24.2B USD | R$1.07K 217.48 USD | R$30.10 6.1 USD | R$30.26 6.13 USD | R$119.40B 24.2B USD | 0 | -R$2.23 -0.4 USD | ||
Alnylam Pharmaceuticals, Inc.
A1LN34.SA
BR
|
R$44.24 8.97 USD |
+0.43
|
R$118.51B 24.02B USD | R$2.10K 426.04 USD | R$44.00 8.92 USD | R$44.88 9.1 USD | R$118.51B 24.02B USD | 8.55 | R$5.17 1.05 USD | ||
Incyte Corporation
ICY.F
DE
|
€105.70 116 USD |
-0.52
|
€21.55B 23.64B USD | €187.00 205.22 USD | €103.80 113.92 USD | €105.80 116.11 USD | €21.55B 23.64B USD | 62.91 | €1.68 1.84 USD | ||
WuXi Biologics (Cayman)
WXIBF
US
|
$5.31 — |
-7.01
|
$21.86B — | $4.00K — | $6.45 — | $6.45 — | $21.86B — | 31.23 | $0.17 — |
|
|
WuXi Biologics (Cayman) Inc.
1FW2.F
DE
|
€4.80 5.27 USD |
-6.43
|
€19.76B 21.68B USD | €800.00 877.96 USD | €4.64 5.09 USD | €4.80 5.27 USD | €19.76B 21.68B USD | 34.28 | €0.14 0.15 USD | ||
WuXi Biologics (Cayman) Inc.
1FW1.F
DE
|
€9.20 10.1 USD |
-6.6
|
€18.94B 20.78B USD | €95.00 104.26 USD | €9.20 10.1 USD | €9.20 10.1 USD | €18.94B 20.78B USD | 34.07 | €0.27 0.3 USD | ||
Alnylam Pharmaceuticals, Inc.
DUL.DE
DE
|
€136.50 149.8 USD |
+0.52
|
€18.28B 20.06B USD | €407.00 446.66 USD | €136.45 149.75 USD | €136.80 150.13 USD | €18.28B 20.06B USD | 7.96 | €17.13 18.8 USD | ||
BioNTech SE
BNTX.VI
AT
|
€73.70 80.88 USD |
-1.8
|
€18.27B 20.05B USD | €0.00 0 USD | €72.95 80.06 USD | €73.85 81.05 USD | €18.27B 20.05B USD | 0 | -€5.88 -6.4 USD | ||
BioNTech SE
22UA.F
DE
|
€73.00 80.11 USD |
-1.35
|
€18.10B 19.86B USD | €55.00 60.36 USD | €72.65 79.73 USD | €73.50 80.66 USD | €18.10B 19.86B USD | 0 | -€5.80 -6.3 USD | ||
Alnylam Pharmaceuticals, Inc.
DUL.F
DE
|
€132.05 144.92 USD |
-2.33
|
€17.69B 19.41B USD | €25.00 27.44 USD | €132.05 144.92 USD | €136.85 150.19 USD | €17.69B 19.41B USD | 7.93 | €16.64 18.26 USD | ||
Innovent Biologics
IVBXF
US
|
$10.93 — |
-0.05
|
$19.05B — | $900.00 — | $11.00 — | $11.06 — | $19.05B — | 109.25 | $0.10 — |
|
|
Innovent Biologics, Inc.
6IB.F
DE
|
€9.18 10.08 USD |
-6.01
|
€16.01B 17.57B USD | €100.00 109.75 USD | €9.18 10.08 USD | €9.20 10.1 USD | €16.01B 17.57B USD | 114.78 | €0.08 0.09 USD | ||
Exelixis, Inc.
EX9.F
DE
|
€59.11 64.87 USD |
-4.85
|
€14.42B 15.83B USD | €20.00 21.95 USD | €59.11 64.87 USD | €59.11 64.87 USD | €14.42B 15.83B USD | 21.57 | €2.74 3.01 USD | ||
BridgeBio Pharma, Inc.
2CL.F
DE
|
€70.31 77.16 USD |
-1.54
|
€13.70B 15.03B USD | €99.00 108.65 USD | €69.98 76.8 USD | €70.31 77.16 USD | €13.70B 15.03B USD | 0 | -€2.57 -2.8 USD | ||
Jazz Pharmaceuticals plc
J7Z.F
DE
|
€209.20 229.59 USD |
-2.56
|
€13.43B 14.74B USD | €50.00 54.87 USD | €209.20 229.59 USD | €213.70 234.53 USD | €13.43B 14.74B USD | 73.92 | €2.83 3.11 USD | ||
Sino Biopharmaceutical
SBHMY
US
|
$14.40 — |
0
|
$12.80B — | $200.00 — | $14.23 — | $14.40 — | $12.80B — | 37.89 | $0.38 — |
|
|
Bio-Techne Corporation
T1CH34.SA
BR
|
R$13.38 2.71 USD |
+0.07
|
R$63.06B 12.78B USD | R$0.00 0 USD | R$13.38 2.71 USD | R$13.38 2.71 USD | R$63.06B 12.78B USD | 70.42 | R$0.19 0.04 USD | ||
Halozyme Therapeutics, Inc.
HALO.MX
MX
|
MX$1,850.00 109.54 USD |
0
|
MX$210.92B 12.49B USD | MX$7.00 0.41 USD | MX$1,850.00 109.54 USD | MX$1,850.00 109.54 USD | MX$210.92B 12.49B USD | 26.20 | MX$70.60 4.18 USD | ||
BioMarin Pharmaceutical Inc.
B1MR34.SA
BR
|
R$157.60 31.94 USD |
0
|
R$61.05B 12.37B USD | R$0.00 0 USD | R$157.60 31.94 USD | R$157.60 31.94 USD | R$61.05B 12.37B USD | 0 | -R$0.26 -0.05 USD | ||
BioMarin Pharmaceutical Inc.
BM8.F
DE
|
€56.12 61.59 USD |
-2.09
|
€10.87B 11.93B USD | €194.00 212.91 USD | €55.52 60.93 USD | €56.18 61.65 USD | €10.87B 11.93B USD | 0 | -€0.08 -0.08 USD | ||
Sino Biopharmaceutical
SBMFF
US
|
$0.66 — |
0
|
$11.83B — | $1.00K — | $0.65 — | $0.65 — | $11.83B — | 33.25 | $0.02 — |
|
|
BioMarin Pharmaceutical Inc.
BMRN.VI
AT
|
€55.58 61 USD |
-2.9
|
€10.77B 11.81B USD | €184.00 201.93 USD | €55.58 61 USD | €56.10 61.57 USD | €10.77B 11.81B USD | 0 | -€0.09 -0.09 USD | ||
BioMarin Pharmaceutical Inc.
BMRN.MX
MX
|
MX$1,021.00 60.46 USD |
0
|
MX$197.76B 11.71B USD | MX$0.00 0 USD | MX$1,021.00 60.46 USD | MX$1,021.00 60.46 USD | MX$197.76B 11.71B USD | 0 | -MX$1.77 -0.1 USD | ||
Sino Biopharmaceutical Limited
SMZ1.F
DE
|
€0.59 0.64 USD |
-3.89
|
€10.40B 11.42B USD | €2.01K 2.21K USD | €0.59 0.64 USD | €0.59 0.64 USD | €10.40B 11.42B USD | 29.25 | €0.02 0.02 USD | ||
Bio-Techne Corporation
TE1.F
DE
|
€65.82 72.23 USD |
-1.76
|
€10.34B 11.35B USD | €10.00 10.97 USD | €64.88 71.2 USD | €65.82 72.23 USD | €10.34B 11.35B USD | 71.54 | €0.92 1.01 USD | ||
Financière de Tubize SA
FTD.F
DE
|
€226.40 248.46 USD |
-2.83
|
€10.08B 11.06B USD | €225.00 246.93 USD | €226.40 248.46 USD | €226.40 248.46 USD | €10.08B 11.06B USD | 105.30 | €2.15 2.36 USD | ||
Financière de Tubize SA
FTD.SG
DE
|
€224.20 246.05 USD |
-1.84
|
€9.98B 10.95B USD | €0.00 0 USD | €224.20 246.05 USD | €231.60 254.17 USD | €9.98B 10.95B USD | 103.31 | €2.17 2.38 USD | ||
Halozyme Therapeutics, Inc.
RV7.F
DE
|
€84.16 92.36 USD |
-2.84
|
€9.60B 10.53B USD | €50.00 54.87 USD | €84.16 92.36 USD | €84.20 92.41 USD | €9.60B 10.53B USD | 25.12 | €3.35 3.68 USD | ||
TG Therapeutics, Inc.
NKB2.F
DE
|
€58.40 64.09 USD |
-4.58
|
€8.83B 9.69B USD | €50.00 54.87 USD | €58.40 64.09 USD | €58.40 64.09 USD | €8.83B 9.69B USD | 106.18 | €0.55 0.6 USD | ||
Jazz Pharmaceuticals plc
JAZZN.MX
MX
|
MX$2,500.00 148.03 USD |
0
|
MX$160.47B 9.5B USD | MX$0.00 0 USD | MX$2,500.00 148.03 USD | MX$2,500.00 148.03 USD | MX$160.47B 9.5B USD | 0 | -MX$121.10 -7.1 USD | ||
Ionis Pharmaceuticals, Inc.
IONS.MX
MX
|
MX$960.00 56.84 USD |
0
|
MX$159.88B 9.47B USD | MX$0.00 0 USD | MX$960.00 56.84 USD | MX$960.00 56.84 USD | MX$159.88B 9.47B USD | 0 | -MX$59.13 -3.5 USD | ||
Vaxcyte, Inc.
5VA.MU
DE
|
€53.50 58.71 USD |
-1.83
|
€8.47B 9.29B USD | €0.00 0 USD | €53.50 58.71 USD | €53.50 58.71 USD | €8.47B 9.29B USD | 0 | -€6.80 -7.4 USD | ||
Krystal Biotech, Inc.
4KB.F
DE
|
€283.80 311.46 USD |
-0.67
|
€8.41B 9.23B USD | €70.00 76.82 USD | €282.90 310.47 USD | €283.80 311.46 USD | €8.41B 9.23B USD | 45.11 | €6.29 6.9 USD | ||
|
Nessun titolo preferito
Non hai ancora azioni preferite, aggiungile ai preferiti per visualizzarle qui |
|||||||||||


